INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136947, 51, 4.0, 4.0, 'g', NULL, NULL, 'Pediatric', X'789cf34dacb0523049d73732c9000013690319', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136948, 51, 50.0, 100.0, 'mg/kg', 'IM', NULL, 'Pediatric', X'789c3335d0353430c84dd7cf4ed74f49ac54f0f4d5f70c5348c92ccb4c494d51283434d23532c950a850303450004a17030042a80dbc', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136949, 51, 2.0, 2.0, 'g', NULL, NULL, 'Pediatric', X'789cf34dacb052304ad74f49ac0400145e0387', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136950, 4490, 13.0, 13.0, 'mcg', 'IV', NULL, 'Adult', X'789c73c92f4e4c4f5570cb2fca2db65208494cca492d513034ce4d4ed75130320553a60660ca1cc2b3b0005386061051434323080d556c686c0ea1a1ba0ca1da8cc0eaf5143cc3e05a8da0b429980600c0d02654', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136951, 4490, 300.0, 500.0, 'mcg', 'IV', 1, 'Adult', X'789cb352303630d035353050c84d4e57f00c53a830d45128c948cd533035d0353430808aa62466e6542a94e69564e6282426e5a42a94e403514e6a516249aa42803f00a9651538', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136952, 4490, 1.7, 15.0, 'mcg/kg', 'PO', NULL, 'Pediatric', X'789cb35270c92f4e2d56284b2caad45130d433d7353455c84d4ed7cf4ed74f49ac5408f00700b25a0a34', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136953, 3728, 0.5, 1.0, 'mg/kg', 'IV', NULL, 'Adult', X'789cf3cc4b294d2ec9cccf53b05530d033d53554c84dd7cf4e57f00c53c82f4b2d52303428d65148cbcfc9c92f4f4d5148aa0429822a4905ca572a18e91a2be466e69596a4162b24162be4a5a6a6a4a600008eaa1b86', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136954, 3728, 10.0, 30.0, 'mg', NULL, NULL, 'Adult', X'789c05c1510a83500c04c0abeca7fd28283d4a4f10f35609e4256022d2db77e63bc51d167a71325a1c238b85655bdf9f15f37c4125509e8fffb01332a68555f3e24027781cd48666945ade85e290b68c3f97c92059', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136955, 3728, 0.1, 0.2, 'mg/kg', 'IV', NULL, 'Adult', X'789c0dcb310e83301044d1abcc050007c91d17a0204229d26ff060acc03ac22b216e1fb74fff4f92d4a8a20b117221d67ca23088a5acf8d02e52e1da47e3da1e47ecbeb13b92a256bd6fbcab84f18df9f544d58db2db76e35777aa150cf01e37e52cc82b24f20f4bdd24c2', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136956, 3728, 10.0, 20.0, 'mg', 'IV', NULL, 'Adult', X'789c73cc2bc94ccd4d2dc94c5648c92fcecc4bd7513034d0353250c84d57f00c53c82f027215ceed49d7cf4ed7cfcdcc53c8cc4b2b2dcecccf030016801329', X'789ced5a6d73db3612fe2b187f9267445b96e35ce2de654671aeb1a669aab1dddc872ac3814888440c022c002a613bf9eff72c284aa2ed563a277373cde993247277b1afcf2e00fd7e90da2a8b352fc4c1393b9858539ab951077d765059458f72ef4b777e7cfc51de8ae2c8d88cbec9e34d4a97585e8a34e69e188683e1d36870129d0c6e06cfce0783f3d3e747cf4e4f07cf4f03ad48bc34da81f2f783d7420bcb55f8eec5a7c07e5397e27caaaf45cabd5c08c633a1fd54bf320edfd8f7c616ee9c9d0c8aecb87833d517a6288c663796a782bd851578f94a96562eb80ecb55b3cd153fe391e73325e8d72feff14b497d1b7eac35e82ebddd152d7ddcd07f7e4fab8cd24af9185a4b9d75ec7b40ab836bcf75ca6d1a8f755a85e77123d4e80eefea35fb071b1c9d45270c6eb8cdd8f81d330b61e116d767088a321f45ca6635112d4904ded76c189db242eaca0bc7b8635a8854a47076c195625227561430812b961a0792dec9203a1d40c2214bb8660e7255cd66f04c0a29d27961b18e374ccce7b08725302891a672ccb5ea771d4e9ef9c9e7c276ccfa914bed85e63a11616198605712b09cff2884862d27d1e068d8d8738cf519a88667d11929482e985cbd850d2c175cf9bc6625d8618c637f676767ac16dc3a66e614d4a91e69bc2b8497092d8810f5e1bb68d84a32e44a36ad06a7b364b59ad4f3ca3d6cd228fd50e924e440215299f075685b1bbf27bfea5a91ecc2d832975ab05eb9ac226801776be3199e2c2472996bae32e1243f9ceab7d7c123de72edc82496d7a581c3489ba97e235393c083306bae2a97b31e0282b854f0a6d41f9a3c8337a43e7c40f5f1c5cf0fe75ae3d8b5f9e377fd2643380274b6f9e65754a38422a385912919a08cce901795137d265c291289f4aac9f9b9ccf226b7fa9436bce5689cd07a98b95aa7d61470d0e46a7c0d0fd0c75457ae0a82b87306323dd6f8287dce5e3cede843be7a317c925b2c82ba6289950874e09448f3555e04ded6a494099d1a1430656fa6aac424c6820d0aba460ad64b72a3389610ae5509487589ccf26ccea5aa2c62d09feaab9ccf5253d446d54ebaf008b9c6674621df782229e5e831a28428af5927ab6cb0b22477a152e0ecd669c85c17ea1005e8a822606b699c8f503dd52c4470aa9de71e1688522a5142ff0a0bf582bc611450134ecaedbd4cd809185799b61d13d7a490bc96404edba1b710d557e1ebc466bb80401eb7e41d49dd986e177587be23eb7e326c97f763cb13af783a32efc77d87c61578e24d9ea6797ddbfde86ef7dd37a47d43da37a47d43da37a4ffd986f42d40f4ddb6b3c7e83d46ef317a8fd1df0a46ff95f0ec2e16ef016d0f687b40db035a07d0f6a0f07f0b0a8fb936da57f55fa2aa27984db8b758ec81cbb9f58166ef343a79ca6a73c8b867c3a3b3e8747574397e17f231c1746191a3eda673aadbe3cf5ec13fb127e19cb24f89aa37ce3d69c319de878d23d56fab0f12b6ac54b37fdd80062c6fa5bba5d29deaad78f0e8e4bd6fcf4e77c04ba678c5d409dc4eeaee76cf1cb722e256447b56dd782a9eacbcd79d39275664744c50b32bbcd5198089bdb255462002d09249737420579127e858f1f48c460c2e007099b1357bb941176e7b11c0373cf14dd4284e01f7ae027835f905f0a7ab600cb000758cc8ced39136d32211ce715b6f64c09fd05c0ac2e6e42bca7c7ca674fdb93d84e4edb821760863bc92d04d96ae1f7718ae5afa98e8e3a48991146da15f188dcd02e2f5e05664a494b0594dad3651e89ac7f43f08f875fdd8999af62922cbd0272e37371ba3d0fe98c38316e0ee6e282ed198848dafc8924e36b61df6c5fa7c49a553fd4acca4923e34eeb60b238a9d7eec64a6e51cd6208c954e8555355c4a8d1b5dd7b19e3c12476c743d62650e5c4ea8941be074e8d7828dc763b267fc0e39fb1320b190bf09b630aa42352e0967624e94ed6d8a5de2da1b6ed15f3d4bc572c69154c830bf80175e4e586fc19d49e512bb82aea16cdcfa1a67c9757975c8125394dcb6038aa193bd8daaa230b8ff602e0fa1de7bfb4bbdbd3b122cf7fa0b619d88af044feed7d615da9784398498a90098baa66e6e1edebb4f50a4d4e6d6fb74273d3a44f39ba976138596193d1934a7ad3476cedbd384661aa7c773691d6132ca5558c05fa6ea445899c2777caa2300be486ed9cd6ba6c44228474ec2948f96e79bd670c12d7013b38bb514825ef98729912c2953e982bb2d70552e2843564dafdb5660204dab2496f0ea7063a6bdd71d31977e51377fc8fc1d26c487b8baa3ea1f6afc151af924e7b6e009b64859dd49a74baee6919273711e86aae57531d2037b17ae0ebf63c327d1df862cb7acc7e73e5c3b4729af574ac2d5ed84e98a73b66ca553fdcf4f281572ec390b0d9bc8929ca3160b1a0e4649f3eef5e8e508cdde508da2b5f312fb320443203d9e0fb07118207d12a3537718b2d2e5e80e8ca6a2668e1c46cf963a438f7ff15bc1aa92357a6ed421dd60b47bb867104a2c8fa84bfa3b1ce56bc77fd742fe86991f2ec4e254af0be96bda1e390949a46a00b656993e9b559e393e6f90a761a63c37162888e115fb2a4058954abab44f7ca3b4abca920c476d6067a81795725426cd453c5524779dfa21ba68799dd2ea84ce7a67fb4a480902145273969742250065022041e8598016d2aeb9c2a1b71f2abb01ea60fbb59236d43615faf56a56ffe5e4fd63ab6b53d0f6bcef9c222c475621e29172e64e949677573dbada82c77e109eeae5cf70e2cbfee1b85a6bd7bf38a266970c1d54582aba5d4a4bf85fc294cf9fff0de0e4ef68', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136957, 3728, 5.0, 50.0, 'mcg/kg', 'IV', NULL, 'Adult', X'789c33d5353550c84d4ed7cf4ed7cfcdcc53f00cd351c8cc4b2e4a4d2c4e55304596293434005200662f0f3e', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136958, 3728, 65.0, 65.0, 'mcg/kg', NULL, NULL, 'Adult', X'789c25cd610a02410840e1ab78806021aa9f7b17716c467235d421ba7d437b80efbd991355bf80994e82c50d3e5203f6c71d0eeadbab6f87183c3d60bfde46e405d01a504809fda5a8c21b4bd82a4f2b46c1982bc5d6bcb3f94ce83ac9c9633197966765fd68b8e25a70fe00c9a13391', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136959, 3728, 2.0, 10.0, 'mg/kg', NULL, NULL, 'Adult', X'789cd34829ca2c5030d23534c84dd7cf4ed7cf28d20400390205bf', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136960, 3728, 2.5, 3.5, 'mg/kg', 'IV', NULL, 'Pediatric', X'789cf3cc4b294d2ec9cccf53d030d6353453a8ccd754482c5130d233d535d63355c84dd7cf4e57f00c0300eaa90b0f', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136961, 3728, 1.0, 1.0, 'mg/kg', NULL, NULL, 'Pediatric', X'789c3354c84dd7cf4e57d0c84dac50303100f23475144a3252f3140cf44ca17201417e107923b03c0074300e36', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136962, 805, 100.0, 100.0, 'mg', NULL, NULL, 'Adult', X'789c73c92f4e4c4f5570cb2fca2db65208494cca492d51303430c84d07007a3b08b6', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136963, 805, 100.0, 100.0, 'mg', 'PO', 2, 'Adult', X'789c333430c84d5708f05770f27451a85030564849ac2c06003b1a05d0', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136964, 805, 100.0, 100.0, 'mg', 'PO', 2, 'Pediatric', X'789c7bd4b9d4a832df4ac1d0c020375d21c05fc1c9d345a142c1582125b1b2180098620954', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136965, 15738, 50.0, 50.0, 'mg', NULL, NULL, 'Adult', X'789c73c92f4e4c4f55082e294acd4b2fc928b6523035c84dd72fcb4cccd1513087310104180d06', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136966, 15738, 50.0, 150.0, 'mg', 'IV', 1, 'Adult', X'789c3335d035343550c84d57f00c534849cccca9040028bc050f', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136967, 15738, 50.0, 70.0, 'mg', NULL, 1, 'Pediatric', X'789c3335d0353750c84dd7cfd530d2544849cccca904002dde0540', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136968, 11770, 50.0, 50.0, 'mg', 'IV', NULL, 'Adult', X'789c3335c84d57f00c53283434ca50a830d53534514849ac2c06004a820685', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136969, 11770, 100.0, 100.0, 'mg', 'IV', NULL, 'Adult', X'789c0b2e492c2ab152303430c84d57f00c53a8300400360e0556', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136970, 11770, 50.0, 50.0, 'mg', 'IV', NULL, 'Adult', X'789c3335c84d57f00c53283434ca50a830d53534514849ac2c06004a820685', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136971, 11770, 100.0, 100.0, 'mg', 'IV', NULL, 'Adult', X'789c0b2e492c2ab152303430c84d57f00c53a8300400360e0556', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136972, 11770, 50.0, 50.0, 'mg', 'IV', NULL, 'Adult', X'789c3335c84d57f00c53283434ca5048cb2f52482c51c8494d2c2e5130554849ac2c06009cae0a10', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136973, 11770, 100.0, 100.0, 'mg', 'IV', NULL, 'Adult', X'789c0b2e492c2a51303430c84d57f00c53a8300400310d051c', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136974, 11770, 1.2, 1.2, 'mg/kg', 'IV', NULL, 'Pediatric', X'789c33d43352c84dd7cf4e57f00c53283434ca000027d504a2', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136975, 11770, 50.0, 50.0, 'mg', NULL, NULL, 'Pediatric', X'789cf34dacb052303550c84dd73734ca00001d7803d4', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136976, 11770, 50.0, 50.0, 'mg', 'IV', NULL, 'Pediatric', X'789c3335c84d57f00c53303434ca0000143f0315', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136977, 11770, 1.2, 1.2, 'mg/kg', 'IV', NULL, 'Pediatric', X'789c33d43352c84dd7cf4e57f00c53283434ca000027d504a2', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136978, 11770, 50.0, 50.0, 'mg', NULL, NULL, 'Pediatric', X'789cf34dacb052303550c84dd73734ca00001d7803d4', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136979, 11770, 50.0, 50.0, 'mg', 'IV', NULL, 'Pediatric', X'789c3335c84d57f00c53303434ca0000143f0315', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136980, 11770, 1.2, 1.2, 'mg/kg', 'IV', NULL, 'Pediatric', X'789c33d43352c84dd7cf4e57f00c53283434ca000027d504a2', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136981, 11770, 50.0, 50.0, 'mg', NULL, NULL, 'Pediatric', X'789cf34dacb052303550c84dd73734ca00001d7803d4', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136982, 11770, 50.0, 50.0, 'mg', 'IV', NULL, 'Pediatric', X'789c3335c84d57f00c53303434ca0000143f0315', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136983, 14130, 500.0, 500.0, 'mg', NULL, NULL, 'Adult', X'789c73c92f4e4c4f5570cb2fca2db652303432d551303235d05130353050c84d5748c92c2e482d2a4e5528494c020017b30cfb', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136984, 14130, 20.0, 30.0, 'mg/kg', 'PO', 1, 'Adult', X'789c3332d0353650c84dd7cf4e5708f057087401002517045c', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136985, 14130, 20.0, 20.0, 'mg/kg', 'PO', 1, 'Adult', X'789c0b2e492c2ab152303250c84dd7cf4e5708f0570874010048620634', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136986, 14130, 40.0, 40.0, 'mg/kg', NULL, NULL, 'Adult', X'789cf34dacb052303150c84dd7cf4ed74f49ac04002cd00547', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136987, 14130, 5.0, 10.0, 'mg/kg', NULL, NULL, 'Adult', X'789c734cc92a2d2e5148c92f4e5548aa5430d5353450c84dd7cf4ed74f49ac542834d635cbcd57484a2c4e4d51c8cf53284e2d2acd55484b2d2aca2cc9cc030058181465', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136988, 14130, 10.0, 10.0, 'mg/kg', NULL, NULL, 'Adult', X'789c73494d2e4a4d2c4e5548c9071286060ab9e9fad9e9fa2989950a99690ace450a76c6c6aa0a8949f965a90a494075399979a90a15460ae5a9a9d9c50067b31411', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136989, 14130, 500.0, 500.0, 'mcg', NULL, NULL, 'Adult', X'789cf3c8cf49b152704b2d2aca2cc9cc53b031353050c84d4ed7f701006bc207e8', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136990, 14130, 10.0, 20.0, 'mg/kg', 'PO', 1, 'Adult', X'789c3334d0353250c84dd7cf4e5708f0570874010024f8045a', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136991, 14130, 10.0, 10.0, 'mg/kg', 'PO', 1, 'Adult', X'789c0b2e492c2ab152303450c84dd7cf4e5708f0570874010048540633', X'789ced5a6d6fdb3610fe2b8700013accae5f12679d5a1470dc976448532f49370c5361d0d259664d911a4925168afef71d65cb916c3776b3146b377f4a28dd1d8fcf3d773c91feb817ea341a4816e39e077b2f70849a19aed574af067ba916eee9d8dac4788dc60d9f60fc58e9c8fdc71b4bc226d02cc170c0acd36937db47f566abde6a5e357ff23a2defa0f5f8e8b07574f4732e8b81e54a1a92fcb8d70d632eb9b19ab967f9238bd3dcca5596a0e7cbaeb43c54167df942191621bc523a361eb4da9d1ab43bcd1a749a4d882308b949501b04cb86bebc50a945036a04d5293c78ab99f0654fc5b19270a55988704e1090c997d30f34ca7d4c8765373fd123b22ad08dfe7c4f23c1e5241fdcfa5b38ba19bc85e4a7f7ce72374c851dd0eab88c2a08acf164ef542b39b06aca036eb3da2018d39807035a9d34a3d4901c131523ed66fdc0e1d39844d07f0bbfbef0e5a565da7ad05e7afc864d3d389c3f6c842c23f0c30fa9b1102a8275984187427afb1afe3aa81fc50a86cc600804a6419dc640c4d0dc724901c34023bd9ce95754f9087a1a9e1f1cec031baa6bcc8d10a808d336dc204e8c2f4f94083d78353707cff2380751e36caf1a0e87e16760914ad64bd0d4434c508628edc08e9960c660cc599dfeaae07105b556b3be0ccf1cb5d63ad4da15d4aaebee34f7b75aeea9b4b4d434b16049dbc6e4a5d36382466106cc42a73cc9323a07053aa034087e8d1a283bdd0b971cafb0112dc37607abefc2f47f47b52d5370c7b587e7da0ed3254cb7df987258fb1872663521f980dbcba05dcdfa7aab0399f2e5f796fe4c86f0fcddd9b92f5b473f7e972b28c8f77536c4a538534acd03fd8f92ab02d37a345c02c9d0e4012a6542a064409ecefab8952cbd67c8bfc9b57c8d8af33576ff5d25f8565650ae045fa15fd995825d29d8116847a01281beb013bd4c30e0b463f455920a765b9c0a46f4354692c920830b7a2b235f7ad07b0a3d963a5908534d0f2129a47c79c6029bdb01cdcdc483b383a770c946683348e544aa1bb9ae165ea0dbb6d634c3f9218ce7cb9eee092ae7f5a3a6070b248d8be2024f2704cfdb53a0e0bb669d54cee0d92129f4940b0397210f98c5d0978bfefb812daf69f84e302138d636fa8bb58db908ebfd341a43cfe5271cdfe5c9b270cf83eeb5e221a4069756f66076bfa0327d9e3a5b9c5eba73cf0597060ed248694eb3cc4ee4fe432c594e80ff1b4dfe5bb9f18545b7c2879592db15027594815510b8d91aee3a600db9842317ad4ad130413d523aa6b4c9bdb7a93b3ce3e4af2bc2be8c33142acc4c42f6087030990cb58ad16d6fd74e298498095ed4f02bea24e2a10a32aba875e0cc97cf3acd5ab349b3cd43063c4e18d76e3baac12a3ce4ed7c83a0bd6abc8d4ad72deab8a2a75db697b42a2fdde69a6aedb6438909f99bf741c0a265c131c6cc2aa1227a1b72a37488ba2420c139474a069e773a99baef2dc3e710de5cf4de5435070b4d9ab774ebb21492cd7657348a5b8d6b771b33b84016ac726f5d69ba44cd555a953bbfc59c7acf392d4ae3d7a70e78a5f59822920f670c9df742344e45e002d18da8534d45eea6e1c4da734cad2e68b74ac4ae74ddab2f71ca487f38b777822cef438432c60597f2975647ff9ea134a01216f0d13cd77c7981b41b11b30a36b854c9f22b2a69a89dbba60510f766e8b8095932ce049b3ae72e7fb9f4e54b9d59c72a88a944719776e8264a27b99fc19c00d7cc04a9207beb4e8166b75c154429bd51e0f56ce7e90e4315e74e12f9c9893e618d5c52b3454baf116ba9298cb9b539d95f70463823bd3967548fe86fc397bf91feac5fbb60664c16cfae4af64fdff617a37beded4b61dbe26e6d49a142ee52cc375b2a0b3f788a94edcda8b6cdb5612e57d12d1372b385b9f420975ef261c1be6d1cb915ae5821da6ed67642d5b92b24dc62fa427e90cb576c9508bcd95059b862a560fa169d642159e5599e1f5b506c2657d12d126ab3f642b2a2efd270b36e2e352bd4bbb2fbcfcbeef256b6abbbbbbabbabbbbbba7b57ddfdd66ac4bd7ef3b4a3d0bf49a1fe98d1b778e0be3ab30a914e9818d5051fa1074feaad238afd1ba4602ac14decc1993b3b7e0abd3ffa879da607eee771f4550e8f9eecfff014debdbef2a0d56dc1a344d3639dfd50a3e101387ab83366da0c5f4e038db31fd3bdc2000d3c39dcafc13bed4e949fecdfe39ce20d066326c9b7811a0dbac1ca4f017b6314ccfd9ccf9d77d720a1aaae1c7c30c2c07dbabb53702c9cbad73949ec3efcab3dd0b160c1048ed5147e675aced2889b095047303f3218312e528df9c73d7dd7df703b86805cd3431e5278ddcf0f35b0e2e0a3744050ea4e4a468bf38b756657cf316a705c839eb3e38e924a66226a50b472e5c1cc1aa19345a7e64ca2a05945766b7a9d83b7a734f355087503898b8140bbaee3d978fc8f38e80aa32a08bb7b25289acafb96a0152377674fe52ecba5d1a74f7f0335eca53d', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136992, 14130, 20.0, 20.0, 'mg/kg', NULL, NULL, 'Adult', X'789cf34dacb052303250c84dd7cf4ed74f49ac04002cb80545', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136993, 14130, 5.0, 5.0, 'mg/kg', NULL, NULL, 'Adult', X'789cf3cc2b492d2a2a2d285128294a4d2cc94dcd2b51c84c5348cc01f2522a15124b144c1572d3f5b3d3f553122b018923105f', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136994, 14130, 300.0, 300.0, 'mcg', NULL, NULL, 'Adult', X'789cf3c8cf49b152704b2d2aca2cc9cc53b031363050c84d4ed7f751c82f52c8c92c4b2d52c82cca074928e4a603d5e9a703009cfb0fe5', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136995, 14130, 20.0, 30.0, 'mg/kg', 'PO', 1, 'Pediatric', X'789c3332d0353650c84dd7cf4e5708f057087401002517045c', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);
INSERT OR REPLACE INTO dosage_guidelines (id, med_id, wikem_min_dose, wikem_max_dose, wikem_dose_unit, wikem_route, wikem_frequency, wikem_patient_category, wikem_instructions, wikem_json_blob, ncbi_indications, ncbi_administration, ncbi_adverse_effects, ncbi_contraindications, ncbi_monitoring, ncbi_mechanism, ncbi_toxicity, ncbi_json_blob, source, created_at, updated_at, structured_dosage, min_dose, max_dose, dose_unit, frequency, route, patient_category) VALUES (136996, 14130, 20.0, 20.0, 'mg/kg', 'PO', 1, 'Pediatric', X'789c0b2e492c2ab152303250c84dd7cf4e5708f0570874010048620634', X'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', NULL, NULL, NULL, NULL, NULL, NULL, NULL, NULL, 'WikEM', 1768170090, 1768170090, NULL, NULL, NULL, NULL, NULL, NULL, NULL);